skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface

Abstract

The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.

Inventors:
;
Publication Date:
Research Org.:
University of Georgia Research Foundation, Inc., Athens, GA (Unites States); Abeome Corporation, Athens, GA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1176025
Patent Number(s):
7,148,040
Application Number:
10/079,130
Assignee:
University of Georgia Research Foundation, Inc. (Athens, GA) ; Abeome Corporation (Athens, GA) OSTI
DOE Contract Number:  
FG07-96ER20257
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Meagher, Richard B., and Laterza, Vince. Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface. United States: N. p., 2006. Web.
Meagher, Richard B., & Laterza, Vince. Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface. United States.
Meagher, Richard B., and Laterza, Vince. Tue . "Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface". United States. https://www.osti.gov/servlets/purl/1176025.
@article{osti_1176025,
title = {Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface},
author = {Meagher, Richard B. and Laterza, Vince},
abstractNote = {The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Dec 12 00:00:00 EST 2006},
month = {Tue Dec 12 00:00:00 EST 2006}
}

Patent:

Save / Share: